Work

A Phase II Study of Tri-Weekly Panitumumab Regimen as a Third-Line Therapy for Patients with Advanced Colorectal Cancer

Year: 2012
Type: article
Study design: Clinical Trial
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W3000406806
FWCI:
Cites:
Cited by:
Related to: 10